Arvind Kumar Yadav
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arvind Kumar Yadav has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Rohit Shukla
4 shared publications- Thirupathihalli Pandurangappa Krishna Murthy
Department of Biotechnology, M S Ramaiah Institute of Technology, Bengaluru, India
3 shared publications - Tiratha Raj Singh
Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology (JUIT), Solan, India
3 shared publications - Aishwarya Girish
Department of Biotechnology, Ramaiah Institute of Technology
2 shared publications - Samruddhi Sutar
Department of Biotechnology, Ramaiah Institute of Technology
2 shared publications - Suheeth Amberi Premanand
Department of Biotechnology, Ramaiah Institute of Technology
2 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 109 (10) , 10209-10227
Subtype-selective binding of milk β-casomorphins across the opioid receptor family revealed by molecular docking and molecular dynamics simulation
β-casomorphins (BCMs) are opioid-like peptides produced during the digestion of β-casein in the gastrointestinal tract. They are also involved in other gastrointestinal and neurophysiological processes. Although the effect of BCM7 on the μ-opioid receptor (MOR) has been extensively studied, the molecular interaction mechanisms of other BCMs with different opioid receptors have not been elucidated. This study aimed to investigate the receptor-specific binding behavior of BCM3-BCM11 across the μ-, δ-, κ-, and nociceptin/orphanin FQ peptide (NOP) opioid receptors using structure-based computational approaches. Three-dimensional structures of BCM peptides were generated and subjected to a peptide docking analysis for each opioid receptor. Comparative analyses of docking scores and binding modes were performed to identify receptor-preferred BCM variants. The selected high-affinity complexes for each receptor were further evaluated using molecular dynamics simulations to assess their structural stability and dynamic behavior. Protein-ligand contact analyses were conducted to characterize the residue-level interaction patterns and interaction persistence over time. Docking analysis revealed pronounced receptor- and peptide-dependent binding profiles. BCM7 exhibited the strongest affinity for MOR, consistent with previous reports. Meanwhile, other receptors showed a preference for distinct BCM variants, including BCM6, BCM9, BCM10, and BCM11, depending on the receptor subtype. Molecular dynamics simulations indicated that the selected BCM-receptor complexes reached stable conformational states after equilibration. Hydrogen bonding, hydrophobic interactions, and water-mediated contacts collectively contribute to peptide stabilization; notable differences are observed in contact composition among receptor subtypes, reflecting subtype-specific recognition features. Overall, this study provides a comparative molecular framework for understanding how structurally diverse BCMs interact with members of the opioid receptor family. These findings demonstrate that BCM7 dominance is largely MOR-specific and that other BCM variants may preferentially engage non-MOR opioid receptors. These results highlight the importance of looking beyond BCM7 and considering both peptide diversity and receptor subtype specificity when investigating BCM-mediated signaling mechanisms.
- 1 October 2026
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 109 (10) , 10209-10227
Open AccessSubtype-selective binding of milk β-casomorphins across the opioid receptor family revealed by molecular docking and molecular dynamics simulation
β-casomorphins (BCMs) are opioid-like peptides produced during the digestion of β-casein in the gastrointestinal tract. They are also involved in other gastrointestinal and neurophysiological processes. Although the effect of BCM7 on the μ-opioid receptor (MOR) has been extensively studied, the molecular interaction mechanisms of other BCMs with different opioid receptors have not been elucidated. This study aimed to investigate the receptor-specific binding behavior of BCM3-BCM11 across the μ-, δ-, κ-, and nociceptin/orphanin FQ peptide (NOP) opioid receptors using structure-based computational approaches. Three-dimensional structures of BCM peptides were generated and subjected to a peptide docking analysis for each opioid receptor. Comparative analyses of docking scores and binding modes were performed to identify receptor-preferred BCM variants. The selected high-affinity complexes for each receptor were further evaluated using molecular dynamics simulations to assess their structural stability and dynamic behavior. Protein-ligand contact analyses were conducted to characterize the residue-level interaction patterns and interaction persistence over time. Docking analysis revealed pronounced receptor- and peptide-dependent binding profiles. BCM7 exhibited the strongest affinity for MOR, consistent with previous reports. Meanwhile, other receptors showed a preference for distinct BCM variants, including BCM6, BCM9, BCM10, and BCM11, depending on the receptor subtype. Molecular dynamics simulations indicated that the selected BCM-receptor complexes reached stable conformational states after equilibration. Hydrogen bonding, hydrophobic interactions, and water-mediated contacts collectively contribute to peptide stabilization; notable differences are observed in contact composition among receptor subtypes, reflecting subtype-specific recognition features. Overall, this study provides a comparative molecular framework for understanding how structurally diverse BCMs interact with members of the opioid receptor family. These findings demonstrate that BCM7 dominance is largely MOR-specific and that other BCM variants may preferentially engage non-MOR opioid receptors. These results highlight the importance of looking beyond BCM7 and considering both peptide diversity and receptor subtype specificity when investigating BCM-mediated signaling mechanisms.
- Open Access
- 20 November 2025
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 1
Computational screening and identification of functional deleterious nsSNPs in the human MAOB gene
- 20 November 2025
- Published by Elsevier in In Silico Research in Biomedicine
- Vol. 1
Open AccessComputational screening and identification of functional deleterious nsSNPs in the human MAOB gene
- 9 January 2024
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 43 (5) , 2503-2517
A computational study on structural and functional consequences of nsSNPs in human dopa decarboxylase
The Dopa Decarboxylase (DDC) gene plays an important role in the synthesis of biogenic amines such as dopamine, serotonin, and histamine. Non-synonymous single nucleotide polymorphisms (nsSNPs) in the DDC gene have been linked with various neurodegenerative disorders. In this study, a comprehensive in silico analysis of nsSNPs in the DDC gene was conducted to assess their potential functional consequences and associations with disease outcomes. Using publicly available databases, a complete list of nsSNPs in the DDC gene was obtained. 29 computational tools and algorithms were used to characterise the effects of these nsSNPs on protein structure, function, and stability. In addition, the population-based association studies were performed to investigate possible associations between specific nsSNPs and arthritis. Our research identified four novel DDC gene nsSNPs that have a major impact on the structure and function of proteins. Through molecular dynamics simulations (MDS), we observed changes in the stability of the DDC protein induced by specific nsSNPs. Furthermore, population-based association studies have revealed potential associations between certain DDC nsSNPs and various neurological disorders, including Parkinson's disease and dementia. The in silico approach used in this study offers insightful information about the functional effects of nsSNPs in the DDC gene. These discoveries provide insight into the cellular processes that underlie cognitive disorders. Furthermore, the detection of disease-associated nsSNPs in the DDC gene may facilitate the development of tailored and targeted therapy approaches.Communicated by Ramaswamy H. Sarma.
- 9 January 2024
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 43 (5) , 2503-2517
A computational study on structural and functional consequences of nsSNPs in human dopa decarboxylase
The Dopa Decarboxylase (DDC) gene plays an important role in the synthesis of biogenic amines such as dopamine, serotonin, and histamine. Non-synonymous single nucleotide polymorphisms (nsSNPs) in the DDC gene have been linked with various neurodegenerative disorders. In this study, a comprehensive in silico analysis of nsSNPs in the DDC gene was conducted to assess their potential functional consequences and associations with disease outcomes. Using publicly available databases, a complete list of nsSNPs in the DDC gene was obtained. 29 computational tools and algorithms were used to characterise the effects of these nsSNPs on protein structure, function, and stability. In addition, the population-based association studies were performed to investigate possible associations between specific nsSNPs and arthritis. Our research identified four novel DDC gene nsSNPs that have a major impact on the structure and function of proteins. Through molecular dynamics simulations (MDS), we observed changes in the stability of the DDC protein induced by specific nsSNPs. Furthermore, population-based association studies have revealed potential associations between certain DDC nsSNPs and various neurological disorders, including Parkinson's disease and dementia. The in silico approach used in this study offers insightful information about the functional effects of nsSNPs in the DDC gene. These discoveries provide insight into the cellular processes that underlie cognitive disorders. Furthermore, the detection of disease-associated nsSNPs in the DDC gene may facilitate the development of tailored and targeted therapy approaches.Communicated by Ramaswamy H. Sarma.
- 29 December 2023
- Published by IGI Global Scientific Publishing
- p. 225-250
Application of Deep Learning in Biological Big Data Analysis
The meaningful data extraction from the biological big data or omics data is a remaining challenge in bioinformatics. The deep learning methods, which can be used for the prediction of hidden information from the biological data, are widely used in the industry and academia. The authors have discussed the similarity and differences in the widely utilized models in deep learning studies. They first discussed the basic structure of various models followed by their applications in biological perspective. They have also discussed the suggestions and limitations of deep learning. They expect that this chapter can serve as significant perspective for continuous development of its theory, algorithm, and application in the established bioinformatics domain.
- 29 December 2023
- Published by IGI Global Scientific Publishing
- p. 225-250
Application of Deep Learning in Biological Big Data Analysis
The meaningful data extraction from the biological big data or omics data is a remaining challenge in bioinformatics. The deep learning methods, which can be used for the prediction of hidden information from the biological data, are widely used in the industry and academia. The authors have discussed the similarity and differences in the widely utilized models in deep learning studies. They first discussed the basic structure of various models followed by their applications in biological perspective. They have also discussed the suggestions and limitations of deep learning. They expect that this chapter can serve as significant perspective for continuous development of its theory, algorithm, and application in the established bioinformatics domain.
- 29 June 2023
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 42 (11) , 5485-5501
Comprehensive bioinformatics analysis of structural and functional consequences of deleterious missense mutations in the human QDPR gene
Quinonoid dihydropteridine reductase (QDPR) is an enzyme that regulates tetrahydrobiopterin (BH4), a cofactor for enzymes involved in neurotransmitter synthesis and blood pressure regulation. Reduced QDPR activity can cause dihydrobiopterin (BH2) accumulation and BH4 depletion, leading to impaired neurotransmitter synthesis, oxidative stress, and increased risk of Parkinson's disease. A total of 10,236 SNPs were identified in the QDPR gene, with 217 being missense SNPs. Over 18 different sequence-based and structure-based tools were employed to assess the protein's biological activity, with several computational tools identifying deleterious SNPs. Additionally, the article provides detailed information about the QDPR gene and protein structure and conservation analysis. The results showed that 10 mutations were harmful and linked to brain and central nervous system disorders, and were predicted to be oncogenic by Dr. Cancer and CScape. Following conservation analysis, the HOPE server was used to analyse the effect of six selected mutations (L14P, V15G, G23S, V54G, M107K, G151S) on the protein structure. Overall, the study provides insights into the biological and functional impact of nsSNPs on QDPR activity and the potential induced pathogenicity and oncogenicity. In the future, research can be conducted to systematically evaluate QDPR gene variation through clinical studies, investigate mutation prevalence across different geographical regions, and validate computational results with conclusive experiments.Communicated by Ramaswamy H. Sarma.
- 29 June 2023
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 42 (11) , 5485-5501
Comprehensive bioinformatics analysis of structural and functional consequences of deleterious missense mutations in the human QDPR gene
Quinonoid dihydropteridine reductase (QDPR) is an enzyme that regulates tetrahydrobiopterin (BH4), a cofactor for enzymes involved in neurotransmitter synthesis and blood pressure regulation. Reduced QDPR activity can cause dihydrobiopterin (BH2) accumulation and BH4 depletion, leading to impaired neurotransmitter synthesis, oxidative stress, and increased risk of Parkinson's disease. A total of 10,236 SNPs were identified in the QDPR gene, with 217 being missense SNPs. Over 18 different sequence-based and structure-based tools were employed to assess the protein's biological activity, with several computational tools identifying deleterious SNPs. Additionally, the article provides detailed information about the QDPR gene and protein structure and conservation analysis. The results showed that 10 mutations were harmful and linked to brain and central nervous system disorders, and were predicted to be oncogenic by Dr. Cancer and CScape. Following conservation analysis, the HOPE server was used to analyse the effect of six selected mutations (L14P, V15G, G23S, V54G, M107K, G151S) on the protein structure. Overall, the study provides insights into the biological and functional impact of nsSNPs on QDPR activity and the potential induced pathogenicity and oncogenicity. In the future, research can be conducted to systematically evaluate QDPR gene variation through clinical studies, investigate mutation prevalence across different geographical regions, and validate computational results with conclusive experiments.Communicated by Ramaswamy H. Sarma.
- 6 July 2022
- Published by Academia.edu in Academia Letters
Bioinformatics: Challenges and Opportunities now and in near future
Bioinformatics: Challenges and Opportunities now and in near future
- 6 July 2022
- Published by Academia.edu in Academia Letters
Bioinformatics: Challenges and Opportunities now and in near future
Bioinformatics: Challenges and Opportunities now and in near future